Ifp Advisors, Inc Zymeworks Inc. Transaction History

Ifp Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$4.82 - $7.7 $1,446 - $2,310	300 New	300 $7,000
Q2 2022 Aug 12, 2022	SELL	$4.82 - $7.7 $1,446 - $2,310	-300 Closed	0 $0
Q3 2021 Oct 06, 2021	BUY	$27.35 - $37.28 $6,153 - $8,388	225 Added 300.0%	300 $9,000
Q1 2021 Apr 30, 2021	BUY	$29.83 - $56.81 $2,237 - $4,260	75 New	75 $2,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $917M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.